| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/17/2023 | 13.12% | Truist Securities | $180 → $190 | Maintains | Buy |
| 10/04/2023 | 5.38% | RBC Capital | → $177 | Reiterates | Outperform → Outperform |
| 09/28/2023 | 7.16% | Truist Securities | $167 → $180 | Maintains | Buy |
| 09/27/2023 | 5.38% | RBC Capital | $159 → $177 | Maintains | Outperform |
| 09/27/2023 | 7.16% | Baird | $172 → $180 | Maintains | Outperform |
| 09/01/2023 | 4.19% | Raymond James | → $175 | Initiates Coverage On | → Outperform |
| 07/13/2023 | 10.14% | Barclays | $175 → $185 | Maintains | Overweight |
| 07/07/2023 | — | William Blair | Initiates Coverage On | → Outperform | |
| 06/15/2023 | — | Redburn Partners | Reinstates | → Buy | |
| 06/13/2023 | 5.97% | Northcoast Research | → $178 | Initiates Coverage On | → Buy |
| 06/08/2023 | -7.72% | JP Morgan | $150 → $155 | Maintains | Overweight |
| 06/07/2023 | -5.34% | RBC Capital | $150 → $159 | Maintains | Outperform |
| 06/07/2023 | -0.58% | Truist Securities | $160 → $167 | Maintains | Buy |
| 06/07/2023 | 1.21% | UBS | $165 → $170 | Maintains | Buy |
| 05/24/2023 | 4.19% | Barclays | $159 → $175 | Maintains | Overweight |
| 05/09/2023 | 7.76% | Jefferies | $141.2 → $181 | Upgrades | Hold → Buy |
| 05/04/2023 | -1.77% | UBS | → $165 | Initiates Coverage On | → Buy |
| 03/20/2023 | -10.7% | JP Morgan | → $150 | Initiates Coverage On | → Overweight |
| 03/08/2023 | -4.74% | Truist Securities | $138 → $160 | Maintains | Buy |
| 03/08/2023 | -10.7% | RBC Capital | → $150 | Reiterates | → Outperform |
| 01/24/2023 | -4.74% | Baird | $155 → $160 | Maintains | Outperform |
| 12/14/2022 | -5.34% | Barclays | $148 → $159 | Maintains | Overweight |
| 12/01/2022 | — | Zelman & Assoc | Initiates Coverage On | → Buy | |
| 09/28/2022 | -16.65% | Baird | $132 → $140 | Maintains | Outperform |
| 07/15/2022 | -11.89% | Barclays | $160 → $148 | Maintains | Overweight |
| 06/16/2022 | -16.65% | Truist Securities | $165 → $140 | Maintains | Buy |
| 06/16/2022 | -4.74% | Barclays | $194 → $160 | Maintains | Overweight |
| 04/25/2022 | -1.77% | Truist Securities | $180 → $165 | Maintains | Buy |
| 04/22/2022 | 15.5% | Barclays | → $194 | Initiates Coverage On | → Overweight |
| 04/13/2022 | — | Deutsche Bank | Downgrades | Buy → Hold | |
| 03/16/2022 | 7.16% | Truist Securities | $200 → $180 | Maintains | Buy |
| 02/28/2022 | — | Jefferies | Downgrades | Buy → Hold | |
| 02/28/2022 | — | HSBC | Upgrades | Hold → Buy | |
| 01/05/2022 | — | Berenberg | Upgrades | Hold → Buy | |
| 12/16/2021 | 19.07% | Baird | → $200 | Initiates Coverage On | → Outperform |
What is the target price for Ferguson (FERG)?
The latest price target for Ferguson (NYSE: FERG) was reported by Truist Securities on October 17, 2023. The analyst firm set a price target for $190.00 expecting FERG to rise to within 12 months (a possible 13.12% upside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ferguson (FERG)?
The latest analyst rating for Ferguson (NYSE: FERG) was provided by Truist Securities, and Ferguson maintained their buy rating.
When is the next analyst rating going to be posted or updated for Ferguson (FERG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ferguson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ferguson was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.
Is the Analyst Rating Ferguson (FERG) correct?
While ratings are subjective and will change, the latest Ferguson (FERG) rating was a maintained with a price target of $180.00 to $190.00. The current price Ferguson (FERG) is trading at is $167.97, which is out of the analyst's predicted range.